Inspection Record

PLZ Corp. — Health Canada Inspection Findings

Health CanadaInspected 2024-08-12 6 findingsLaboratory and QC controlsOther quality systemStability and storageEquipment and facility

View the regulator's official source The source document is always the basis for judgement.

Findings

1Laboratory and QC controls

The quality control department did not undertake all of the required activities.

2Other quality system

The handling of standard operating procedures for good manufacturing practices was inadequate.

3Stability and storage

The temperature and/or humidity control was inadequate.

4Equipment and facility

The availability, content and/or maintenance of the quality agreements between the supplier, fabricator, tester, packager, labeller, distributor, importer, and/or wholesaler was inadequate. The importer did not ensure that the foreign sites use to fabricate, package/label, or test drug products met the requirements described in Guidance on Evidence to Demonstrate Drug GMP Compliance of Foreign Sites (GUI-0080).

5Other quality system

Periodic confirmatory testing was not conducted.

6Laboratory and QC controls

The duties of the individual in charge of the quality control department were delegated to an unqualified individual.

About this record

Extracted automatically from the document of the Health Canada inspection on 2024-08-12. The source is available at the link above.

This is a record of that moment. Inspection findings are usually followed by the company's response and corrective action, but this page does not know how that turned out. Do not read it as the current state; check the regulator's official announcements for the latest status.

Translation and classification are automated and may differ in nuance from the source.

Other records for this company

PLZ Corp. findings history — including this company's other documents Health Canada documents, 2024 Go to Findings search